Inducible nitric oxide synthase (iNOS) gene transfer is reported to augment erectile responses in rats, although it is also shown to impair vasorelaxation in cerebral arteries. We investigated the effect of endothelial cell-based iNOS gene transfer on endothelial NOS (eNOS) expression and mouse erectile responses. Human coronary artery endothelial cells (EC) transduced with empty vector (control) or iNOS were grown in culture and transplanted into the corpus cavernosum of severe combined immunodeficient mice. Endothelial NOS expression was compared in control and iNOS-transduced cells grown in the presence or absence of a selective iNOS inhibitor, L-N6-(1-iminoethyl) lysine hydrochloride (L-NIL). At 3-5 days after cell transplantation, we recorded intracorporal pressure (ICP) responses to cavernosal nerve stimulation and measured cavernosal total NO and eNOS protein expression. In this study, EC transduced with iNOS produced significantly more NO than controls but exhibited a twofold downregulation of eNOS protein and mRNA. This effect was reversed by L-NIL. In vivo, the cell-based gene transfer of iNOS led to significantly increased ICP responses, compared to mice transplanted with control ECs. Consistent with the in vitro data, cavernosal lysates had significantly reduced eNOS expression. In conclusion, EC gene transfer of iNOS downregulates EC expression of eNOS by an NOS-dependent mechanism. In the cavernosum of mice transplanted with Inos-transduced EC, nerve-stimulated erectile responses were augmented by the short-term gene transfer. However, our findings suggest that iNOS gene transfer may have deleterious effects on endothelial function if used as a treatment for erectile dysfunction.
Introduction
Gene transfer of inducible nitric oxide synthase (iNOS) increases local nitric oxide delivery and has been shown to enhance erectile function in rats. 1, 2 However, iNOS overexpression can reduce constitutive endothelial NOS (eNOS) expression and/or activity and endothelium-dependent smooth muscle relaxation, thus complicating its use for gene therapy applications. In vivo, LPS induction of iNOS leads to reduced glomerular filtration by inhibition of eNOS. 3 Inducible NO synthase adenoviral transfer has been associated with impaired NOdependent cerebral artery smooth muscle relaxation in vivo and in vitro. 4, 5 The mechanism of this impaired vasomotor function is uncertain, but eNOS is tightly regulated by transcriptional, post-transcriptional, and post-translational mechanisms. 6 Shear stress, cyclic strain, growth factors and cytokines upregulate eNOS, whereas TNF-a, high concentrations of oxidized LDL and hypoxia downregulate eNOS expression. In human coronary artery endothelial cells (EC), NO serves as a negative feedback regulator of eNOS protein expression via a cGMP-mediated process. 7 If such a regulatory mechanism occurs with cavernosal iNOS gene therapy, impairment of penile erectile responses may result. Thus, we devised complementary in vitro and in vivo strategies to test the hypothesis that high NO production from iNOS gene transfer causes downregulation of eNOS in vascular EC and the corpus cavernosum.
Experimental procedures
Experimental animals SCID mice (Jackson) 8-10 weeks of age were used for in vivo experiments. The Institutional Animal Care and Use Committee of the University of Washington approved all experimental procedures, which were carried out in accordance with the NIH Guide for the Care and Use of Laboratory Animals.
Experimental design
Effect of inducible nitric oxide synthase gene transfer on endothelial nitric oxide synthase expression in vitro. To test the hypothesis that iNOS gene transfer downregulates eNOS, we measured eNOS protein and gene expression in retroviral iNOStransduced human coronary artery EC. Cells transduced with empty vector (control) or iNOS were selected and grown with and without L-NIL (1 mM, Sigma, St Louis, MO, USA). A substrate analog inhibitor of NOS, L-NIL, has 14-28-fold greater selectivity for iNOS than for constitutive NOS isoforms. [8] [9] [10] NO production ([NO 2 À ]) and eNOS expression were measured in duplicate in three independent experiments.
Effect of inducible nitric oxide synthase gene transfer on endothelial nitric oxide synthase expression and erectile responses in mouse corpus cavernosum. We used cell transplantation to investigate the effects of iNOS gene transfer on erectile responses and eNOS expression in vivo. Human coronary artery EC transduced with empty vector or iNOS were transplanted 11 into the cavernosal sinusoids of SCID mice. After 3-5 days, erectile responses were determined by electrical stimulation of the cavernosal nerve. Penile shaft tissue was removed for nitrite/nitrate measurement and Western blotting of eNOS. Immunohistochemistry localized transplanted cells.
Experimental methods Cell culture. Human embryonic kidney 293T amphotrophic packaging cells (Phoenix, provided by G Nolan, Stanford University) were grown on uncoated plastic tissue culture dishes, detached with 0.05% trypsin (Gibco, Carlsbad, CA, USA), and maintained in Dulbecco's Modified Eagle's Medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine (Cambrex, East Rutherford, NJ, USA), 10 000 m/ml penicillin, 10 000 m/ml streptomycin and 25 mg/ml fungizone (P/S/F). Human coronary artery EC (Clonetics, East Rutherford, NJ, USA) were maintained in Medium 199 (Gibco) supplemented with 20% FBS, EGM-2MV cofactors (Clonetics), L-glutamine and P/S/F. Endothelial cells were grown on 2% gelatin type B (Sigma)/15% FBScoated tissue culture dishes and detached with 0.25% trypsin/1 mM EDTA (Gibco). All cells were grown in a humidified incubator at 371C and 5% CO 2 with media changed every 2-3 days.
Generation of retroviral vectors. Retroviral expression vectors were derived from the Maloney murine leukemia virus 12 retroviral vector backbone, pBM-IRES-Neo (Phoenix, provided by G Nolan) modified to include a Puromycin (Puro) resistance gene after the internal ribosome entry site (IRES). 13 This vector, designated pBM-IRES-Puro, was used to generate the iNOS expression vectors. A control vector containing eGFP before the IRES site, designated pBM-eGFP-IRES, was used to test vector efficiency.
The human hepatocyte iNOS gene 14 containing the complete cDNA-coding sequence for iNOS (3.7 kb) was cloned into the XhoI/HindIII sites of the peGFP-C3 (Clonetech) vector as an in-frame fusion to the C terminus of eGFP (provided by B Pitt, University of Pittsburgh). This 4.2 kb fragment, eGFP-iNOS, was released with Nhe1/SalI digest and subcloned into a modified pGEM vector, p34E, 15 containing SalI sites on both sides of the polylinker. The eGFP-iNOS fragment was released from p34E with SalI and cloned into the pBM-IRES-Puro vector at the XhoI sites (dephosphorylated with calf intestinal alkaline phosphatase (New England BioLabs, Ipswich, MA, USA)) using T4 DNA ligase to create pBM-eGFP-iNOS-IRES (Figure 1 ). We created a second vector with only iNOS by digesting the eGFP-iNOS fragment with XhoI before cloning to create pBM-iNOS-IRES (Figure 1 ). Ligation reactions of 10 ml were incubated overnight at 41C before transforming DH5alpha cells. Double digest with SalI and XhoI verified correct orientation of the insert.
Production of retrovirus. Phoenix packaging cells 13 were plated at 2.5 Â 10 6 cells per 60 mm Petri plates containing 4 ml growth medium. At 80% confluence, medium was replaced with fresh medium containing 25 mM chloroquine. Retroviral plasmid DNA (10 mg) and 62 ml 2 M CaCl 2 were diluted in nanopure H 2 O for a total volume of 0.5 ml and were gently mixed. This mixture was then mixed aggressively into 0.5 ml HBS buffer (pH 7.05) for 10 s and immediately dripped evenly over the cells. The medium was changed at 10 h to remove chloroquine and again at 24 h, after which retroviral particles were collected for 24 h. Medium containing viral particles was removed, filtered through a Millex-HV filter (Millipore) and snap frozen on dry ice before storage at À801C.
Retroviral transduction. Subconfluent human coronary artery EC in 60 mm Petri plates were transduced for 24 h with a 1:1 mixture of retroviral supernatant and fresh medium in the presence of 4 mg/ml polybrene to give a multiplicity of infection of 5-10 (3T3 Effect of endothelial cell-based iNOS gene transfer H Wessells et al cells were used to determine viral particle concentration for thawed retrovirus). Cells were allowed to recover for 24 h, before selection for 24-48 h in fresh medium containing 2 mg/ml Puromycin. Transduction efficiencies of transduced EC were determined by flow cytometry before selection.
Flow cytometry. Cells were trypsinized, washed with PBS, centrifuged and fixed with 4% PFA. After fixation, the number of eGFP (FITC) positive cells was determined using a FACScan flow cytometer (Becton Dickinson) and data analysis with CellQuest software.
In vitro nitric oxide assay. Nitric oxide production from transduced cells was indirectly measured by quantifying reduced nitrite ions ([NO 2 À ]) in conditioned media, using an ISO-NO Mark II amperometric NO meter (World Precision Instruments (WPI, Sarasota, FL, USA)) and verified using the Greiss reaction. 16 The device was calibrated using diluted 50 mM KNO 2 standard solution (WPI) added to solution 1 (0.1 M H 2 SO 4 and 0.1 M KI) at room temperature, resulting in an equimolar conversion of nitrite to NO. A calibration curve was generated using the nitrite standard solution. Samples were diluted 1:100 in solution 1 and NO release was recorded using Duo18 software (WPI).
Cell transplantation. We adapted our previously described methods used in rats to transplant EC into the mouse cavernosum. 11 Briefly, mice were anesthetized with 5% isoflurane (Novaplus, Irving, TX, USA) vaporized in 0.8 l/min O 2 with a Landmark vaporizer (Vetland Medical, Louisville, KY, USA), and placed on a heating pad. The penile shaft was exposed via a scrotal incision and encircled with a vessel loop. Using an operating microscope (Nikon), a 30-gauge needle was inserted into the corpus cavernosum to inject, over a 1 min period, a 50-ml suspension of 1 Â 10 6 human endothelial EC that had been trypsinized and resuspended in PBS immediately before transplantation. Mice were recovered and returned to the animal care facility.
In vivo measurement of erectile function. We modified our previously described rat neurostimulation protocol to measure intracorporal pressure (ICP) in anesthetized mice. 17 The cavernosal nerve was stimulated for 1 min at 2 V to assess proper electrode and cannula placement followed by a voltage response series at 2, 4 and 6 V (16 Hz). Each stimulation was separated by 10 min. We report responses as change in ICP (maximumbaseline ICP) in mm Hg. Following ICP measurements, the penis was processed for cryosectioning and protein isolation as previously described. 18 Histology and immunohistochemistry. Standard immunohistochemistry techniques were used on 8 mm frozen sections as previously described. 19 Primary monoclonal antibodies were mouse antihuman iNOS (Transduction Labs, Franklin Lakes, NJ, USA, 20 mg/ml); mouse anti-human phycoerythrin (PE)-conjugated CD 31 (BD 340297, 100 mg/ml) and rat anti-mouse CD31 (Chemicon, Temecula, CA, USA, CBL1337, 20 mg/ml). Secondary antibodies as indicated were rabbit anti-mouse IgG Alexa 568 and goat anti rat IgG Alexa 488 (Molecular Probes, Carlsbad, CA, USA, 10 mg/ml). Slides were mounted and cover slipped using Gel Mount (Biomeda, Foster City, CA, USA). Fluorescent images were captured using a Nikon Eclipse E600 microscope integrated with an RT color Spot CCD camera and software (Diagnostic Instruments, Sterling Heights, MI, USA).
Total nitric oxide assay for tissue lysates. Total NO production [NO 2 À /NO 3 À ] from homogenized cavernosal tissue was measured using the Total NO Assay Kit (Assay Designs, Ann Arbor, MI, USA) according to the manufacturer's instructions. Supernatants from cavernosal lysate for each sample were added in duplicate to a 96-well plate containing NADH (25 ml), after which nitrate reductase (25 ml) was added to each sample and incubated at 371C for 
Griess reagents I (50 ml) and II (50 ml) were added and the plate was gently mixed (30 s) on an orbital shaker. The plate was incubated at RT for 10 min before reading optical density at 550 nM using a plate reader (Molecular Devices, Sunnyvale, CA, USA). Mean values for each animal were calculated from the duplicate samples.
Western blot analysis. Cavernosal tissue was processed for Western blot analysis as previously described. 18 Cells were washed twice with cold PBS and lysed in 1 ml RIPA buffer (50 ml PBS with 0.5 g. NP-40, 0.25 g Na deoxycholate, 0.05 g SDS) containing fresh protease inhibitors and placed on ice for 1 h. Equal amounts of protein (50 mg for tissue, 10 mg for cells) were run on precast polyacrylamide gels (GeneMate, Kaysville, UT, USA) and transferred to PVDF membrane (Millipore, Billerica, MA, USA). 18 Membranes were incubated with primary mouse monoclonal anti-human eNOS antibody (Transduction Labs, 1:2500). 20 The primary antibody was detected with horseradish peroxidaseconjugated anti-mouse secondary antibody (Sigma) diluted at 1:1000 in blocking solution. Blots were developed with enhanced chemiluminescence reagents (Amersham, Piscataway, NJ, USA) and the results were quantified by densitometry using Lab Works Image acquisition and analysis software (UVP Inc., Upland, CA, USA).
Conventional semiquantitative polymerase chain reaction. Total RNA was isolated from cells using RNeasy mini kit (Qiagen, Valencia, CA, USA) and first-strand cDNA was produced with the RETROscript kit (Ambion, Austin, TX, USA). Primers were synthesized (Invitrogen, Carlsbad, CA, USA) and diluted to 100 pmol for RT-polymerase chain reaction (PCR) of eNOS, iNOS and b-actin. AAT GTC ACG CAC GAT TTC CC 3 0 . Polymerase chain reaction was performed as previously described. 18 Statistical analysis. For each condition used, n is the total number of animals or individual replicate wells , and this was the n used in the analysis. All data are expressed as mean7s.e.m. Differences in mean ICP values, NO levels, and eNOS densitometry were compared with one-way analysis of variance (ANOVA) and post hoc testing using Newman Keuls Multiple Comparison Test. The level of significance was chosen as P ¼ 0.05.
Results

Retroviral gene transfer of inducible nitric oxide synthase
The transduction efficiency of the retroviral vectors was 39% for pBM-eGFP and 6% for pBM-eGFPiNOS. All cells were subsequently expanded under Puromycin selection prior to use. We achieved stable transgene expression as determined by increased NO production, immunofluorescence, and RT-PCR (Figure 2) . Morphology of transduced human coronary artery EC were not different compared to controls, nor was there an increase in apoptosis (data not shown).
Effect of inducible nitric oxide synthase gene transfer on endothelial nitric oxide synthase expression in vitro Transduction of human coronary artery EC with pBM-eGFP-iNOS caused a significant decrease in eNOS mRNA and protein expression, compared to controls (Figure 3a-c) , which was associated with a significant increase in [NO 2 À ] (Figure 3d) . Inhibition of iNOS with L-NIL reduced NO release to control levels and substantially reversed this downregulation of eNOS. Experiments using pBM-iNOS-IRES (same vector as used in vivo) also caused a downregulation of eNOS protein and mRNA (data not shown). 
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Cell transplantation. Immunohistochemistry for human and mouse CD31 localized the transplanted human EC within the mouse cavernosum (Figure 5a and b). Cells expressing human CD31 were identified within the lacunar spaces, surrounded by mouse endothelium. Although some cells remained aggregated near the site of injection, spreading and intercalation in small vascular spaces was evident. We immunostained for human iNOS protein to confirm that the iNOS-transplanted cells continued to express the transgene in vivo (Figure 6a and b) .
Cavernosal endothelial nitric oxide synthase expression and nitric oxide levels. Penile shaft tissue lysates from mice transplanted with iNOS-transduced cells showed a twofold downregulation of eNOS protein as compared to controls (Figure 7a and b). The [NO 2 À /NO 3 À ] in the corresponding tissue lysates was elevated, although not significantly, by twofold in the cavernosum of mice transplanted with iNOS cells (Figure 7c) . To confirm the specificity of the eNOS band (obtained with a monoclonal antibody raised in mice), we immunoblotted penile lysates with an isotype-specific mouse IgG primary antibody as a negative control. No band was seen at the expected location (data not shown). Furthermore, using another commercially available eNOS antibody (rabbit polyclonal, Transduction) we obtained similar results (data not shown).
Discussion
Using retroviral vectors and cell culture, we demonstrated that iNOS gene transfer caused downregulation of eNOS at the transcriptional level via an iNOS-specific mechanism. These in vitro observations were confirmed in vivo using a novel mouse model of cell-based cavernosal gene transfer. Transplantation of iNOS-transduced EC augmented penile erectile responses and tissue NO levels but was associated with a significant reduction in eNOS protein expression. In the cavernosum, the release of NO derived from nitrergic nerves and/or iNOS appeared to supersede any deleterious effects of reduced eNOS expression. In other vascular systems that lack neuronal NOS signaling, impairment of endothelium-dependent vasorelaxation by iNOS may have physiological significance.
Human coronary artery EC transduced with iNOS had significantly reduced levels of eNOS mRNA and protein after selection and growth in standard culture conditions. These findings parallel previously published work in which the NO donor Effect of endothelial cell-based iNOS gene transfer H Wessells et al S-nitroso-N-acetyl penicillamine (SNAP) caused downregulation of eNOS in the same cell type. 7 The reversal of eNOS downregulation by L-NIL suggests a NOS dependent mechanism of eNOS downregulation, and not a non-specific effect of retroviral gene transduction such as insertional mutation. 21, 22 The elevated nitrite levels measured in the iNOStransduced EC, but not L-NIL treated cells, support a mechanism related to NO or one of its downstream mediators. However, iNOS overexpression could also downregulate eNOS via a superoxide-mediated mechanism, independent of NO. 23 Several mechanisms have been proposed to explain how NO regulates eNOS protein expression: cGMP-dependent mechanisms, 7, 24 direct binding of NO to the heme moiety 25 or reductase domain 26, 27 of eNOS, or indirectly via p21 28 or p53. 29 Preferential binding to iNOS of cofactors required for eNOS activity (BH4, FAD, NADPH) is not consistent with the transcriptional regulation of eNOS. 6 The effect of NO on eNOS appears to depend on the species and source of EC. For instance, eNOS protein expression is downregulated by NO in human coronary artery EC, 7 whereas in bovine pulmonary artery EC, NO and cGMP increase eNOS expression. 24, 30 NO inhibits eNOS enzyme activity in sheep pulmonary artery and bovine aortic EC. 31, 32 Our in vivo finding of increased erectile responses with cavernosal iNOS gene transfer confirms reports of other investigators in which iNOS was overexpressed by injection of plasmid DNA 1 or adenovirus-transfected myoblasts 2 in the cavernosa of rats with erectile dysfunction. The SCID mouse model for cavernosal gene transfer allowed us to work with commercially available human EC used by Vaziri and Wang, 7 rather than autologous cells as in our prior studies. 11 The magnitude of increase in ICP in the current study was similar to prior publications, although we measured responses at an earlier time point than Rajfer and associates. 1 The downregulation of eNOS protein seen in vitro and in cavernosal tissue of SCID mice transplanted with iNOS-transduced EC provides a potential explanation for the observations of Heistad and associates, 5 that adenoviral iNOS gene transfer impairs endothelium-dependent responses in cerebral vessels. High levels of NO localized to the intima could inhibit eNOS expression or activity. Given recent evidence demonstrating a role for eNOS dysfunction in diabetes-associated erectile dysfunction, 33 it is plausible that longer term studies would demonstrate adverse physiological consequences of eNOS downregulation.
The interpretation of our data must take into account two possible sources of eNOS protein measured in our model: mouse cavernosal EC and transplanted human EC. Inducible NO synthase gene transfer could downregulate eNOS in either cells. The antibodies available for Western blotting recognize both human and mouse eNOS. We used the entire penile shaft for tissue homogenization and protein isolation; the relative amount of eNOS protein in 10 6 transplanted EC is expected to be small compared to the total endothelial mass of the penile shaft, making it unlikely that transplanted EC alone caused the differences seen between the control and iNOS groups. In our hands, immunohistochemical labeling of eNOS was not sufficiently intense to allow quantitative comparisons of expression levels between groups (data not shown).
This study has several other limitations. We used L-NIL to inhibit iNOS in vitro; a way to determine whether NO itself was the cause of eNOS downregulation would have been to use hemoglobin to remove NO from the media. 7 The associated increase in NOS activity, measured in the current study via total nitrite and nitrate concentrations, lacked statistical significance. Use of a more sensitive assay for NOS activity, such as the citrulline or cGMP assay, might have been a more robust endpoint. The small number of animals in each group may also have contributed to the lack of statistical significance of the in vivo total NO levels. A final limitation of our study is that, owing to lack of available expertise with myography, we were not able to determine whether the iNOS overexpression caused impaired endothelium dependent relaxation of cavernosal strips ex vivo.
In conclusion, our data show that EC-based iNOS gene transfer in mice leads to enhanced cavernosal ICP responses without priapism. However, eNOS expression in vitro is downregulated by retroviral transduction of iNOS, and transplantation of these cells into the corpus cavernosum is also associated with reduced eNOS expression in vivo. These results support the hypothesis that gene transfer of iNOS may selectively alter vascular tissue function via a NOS-specific effect on the endothelium, although in the short-term, any physiological effect of downregulated eNOS in the cavernosum was superseded by increased NO production. Future gene transfer studies using iNOS will need to control for this potential unwanted effect.
